Shenzhen YHLO Biotech Future Growth
Future criteria checks 5/6
Shenzhen YHLO Biotech is forecast to grow earnings and revenue by 29.2% and 22.5% per annum respectively. EPS is expected to grow by 28.7% per annum. Return on equity is forecast to be 17.7% in 3 years.
Key information
29.2%
Earnings growth rate
28.7%
EPS growth rate
Medical Equipment earnings growth | 24.1% |
Revenue growth rate | 22.5% |
Future return on equity | 17.7% |
Analyst coverage | Low |
Last updated | 29 Apr 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,463 | 793 | N/A | 833 | 3 |
12/31/2025 | 2,792 | 630 | N/A | 719 | 5 |
12/31/2024 | 2,273 | 476 | N/A | 723 | 3 |
3/31/2024 | 1,824 | 340 | -339 | 359 | N/A |
12/31/2023 | 2,053 | 355 | -736 | -73 | N/A |
9/30/2023 | 2,397 | 424 | -333 | 292 | N/A |
6/30/2023 | 2,719 | 488 | -214 | 419 | N/A |
3/31/2023 | 3,271 | 582 | 66 | 663 | N/A |
12/31/2022 | 3,981 | 1,012 | 1,018 | 1,583 | N/A |
9/30/2022 | 3,450 | 923 | 412 | 933 | N/A |
6/30/2022 | 2,967 | 782 | 381 | 816 | N/A |
3/31/2022 | 2,312 | 678 | 501 | 813 | N/A |
12/31/2021 | 1,178 | 205 | -113 | 260 | N/A |
9/30/2021 | 1,147 | 216 | -45 | 253 | N/A |
6/30/2021 | 1,118 | 198 | -26 | 230 | N/A |
3/31/2021 | 1,020 | 198 | -38 | 230 | N/A |
1/1/2021 | 999 | 211 | 93 | 282 | N/A |
12/31/2019 | 877 | 108 | -60 | 68 | N/A |
12/31/2018 | 729 | 38 | -157 | 30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688575's forecast earnings growth (29.2% per year) is above the savings rate (2.9%).
Earnings vs Market: 688575's earnings (29.2% per year) are forecast to grow faster than the CN market (24.2% per year).
High Growth Earnings: 688575's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688575's revenue (22.5% per year) is forecast to grow faster than the CN market (14.7% per year).
High Growth Revenue: 688575's revenue (22.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688575's Return on Equity is forecast to be low in 3 years time (17.7%).